XML 47 R36.htm IDEA: XBRL DOCUMENT v3.26.3
Stock-based Compensation (Tables)
9 Months Ended
Sep. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Total Stock-Based Compensation Expense
The Company recognized total stock-based compensation expense during the three and nine months ended September 30, 2026 and 2025 as follows (table in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Service-based Awards:
Restricted Stock Units$213 $263 $553 $744 
Stock Option Awards178 269 720 615 
Total$391 $532 $1,273 $1,359 
Schedule of Restricted Stock Awards
A summary of the Company’s performance-based restricted stock awards during the nine months ended September 30, 2026 is as follows:
Performance-based Restricted Stock AwardsNumber of SharesWeighted Average
Grant-Date
Fair Value
Unvested at January 1, 202689 $627.00 
Forfeited(89)$627.00 
Unvested at September 30, 2026— $— 
Schedule of Restricted Stock Units
A summary of the Company’s service-based restricted stock units during the nine months ended September 30, 2026 is as follows:
Service-based Restricted Stock UnitsNumber of SharesWeighted Average
Grant-Date Fair Value
Unvested at January 1, 2026115,666 $11.10 
Granted138,165 5.19 
Vested(38,332)11.40 
Forfeited(3,500)10.70 
Unvested at September 30, 2026211,999 $7.21 
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions
The fair value of the service-based stock option awards granted during the nine months ended September 30, 2026 and 2025 were based on the following assumptions:
Nine Months Ended September 30, 2026Nine Months Ended September 30, 2025
Exercise price$5.19
$10.70 - $12.60
Expected stock price volatility90.9%
90.4% - 91.2%
Risk-free interest rate4.28%
3.74% - 4.14%
Term (years)5.86
5.62 - 5.86
Schedule of Stock Options Activity
A summary of the Company’s service-based stock option activity for the nine months ended September 30, 2026 is as follows:
Service-based Stock Option AwardsShares
Underlying
Options
Weighted
Average Exercise
Price
Weighted
Average
Remaining
Contractual
Term
Aggregate
Intrinsic Value
(in thousands)
Outstanding at January 1, 2026327,627 $26.40 — 
Granted47,250 5.19 
Forfeited(9,851)11.61 
Expired(5,374)70.23 
Outstanding at September 30, 2026
359,652 $23.20 7.57$— 
Exercisable at September 30, 2026
201,953 $32.70 6.67$—